Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.

Oncol Lett · 2020 · PMC7583842 · PMID 33123247

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

We investigated the relationship between HER3-high and PFS among HGSC patients and showed a trend toward worse PFS than that of HER3-low in the present study, although the difference was not significant due to a small sample size.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.